ROSCAP: Reduction of Smoking in Cardiac Patients Study

National Institutes of Health (NIH)

Status: Completed

Conditions: Tobacco Dependence; Nicotine Dependence; Cardiac Disease

Treatments: Behavioral: smoking reduction intervention (including NRT)

Study type: Interventional

Funder types: NIH

Identifiers

NCT00301626

DA13333-02

Details and patient eligibility

About

Background. The ROSCAP Study was a randomized controlled trial in heart disease patients to test the effect of a smoking reduction intervention on cigarettes per day (cpd) and biochemical and clinical indicators of tobacco exposure. .

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• smoked at least 15 cigarettes per day and had one of 11 cardiovascular disorders: history of myocardial infarction, coronary artery bypass surgery, angioplasty, stent placement, thrombolytic therapy, angina, arrhythmia, a history of cardiac arrest, greater than 50% coronary artery stenosis by angiography, ischemia on exercise tolerance testing or congestive heart failure, required to confirm that they were unwilling or uninterested in setting a stop smoking date in the next 30 days.

Exclusion criteria

• 1. unstable angina within the past 2 weeks, 2) unstable psychiatric or substance use disorders or 3) contraindications to nicotine replacement therapy (including pregnancy or intention to become pregnant)